CLDI
Calidi Biotherapeutics Inc.
NYSE MKT: CLDI · HEALTHCARE · BIOTECHNOLOGY
$0.22
+7.53% today
Updated 2026-04-30
Market cap
$2.46M
P/E ratio
—
P/S ratio
50.83x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$0 – $13
Volume
4.3M
Calidi Biotherapeutics Inc. (CLDI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-701.00%
ROA
-109.80%
Debt/equity
0.45x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-7.94M | — | — | — |
| 2021 | $449000.00 | $-10.93M | 79.06% | -2,334.52% | -2,434.97% |
| 2022 | $45000.00 | $-25.43M | -508.89% | -51,395.56% | -56,504.44% |
| 2023 | $0.00 | $-29.22M | — | — | — |
| 2024 | $0.00 | $-22.14M | — | — | — |
| 2025 | $0.00 | $-19.91M | — | — | — |